Anne-claire C. Toffart
Grenoble, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 79 publications
Fusion isoform multiplicity and impact on treatment outcomes in ALK-rearranged non-small cell lung cancer with next-generation tyrosine kinase inhibitors.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 11, 2026
Impact of Immune Checkpoint Inhibitor-Combined Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer With Brain Metastases.
Journal: Clinical lung cancer
Published: January 28, 2026
Adjuvant Durvalumab in Completely Resected Early-Stage Non-Small Cell Lung Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 13, 2026
Timeliness of discharge summary and post-discharge adverse events among patients hospitalised for community-acquired pneumonia.
Journal: International journal for quality in health care : journal of the International Society for Quality in Health Care
Published: December 04, 2025
Defining intensive care status in metastatic lung cancer patients: A French survey.
Journal: Respiratory medicine and research
Published: December 02, 2025
Four-Year Outcomes of First-Line Nivolumab Plus Ipilimumab for 6 Months Versus Continuation in Patients With Advanced NSCLC: Results of the Randomized IFCT-1701 "DICIPLE" Phase III Trial.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: October 15, 2025
Nintedanib as switch maintenance treatment in malignant pleural mesothelioma (NEMO): A double-blind randomized phase II trial (EORTC-08112-LCG).
Journal: Lung cancer (Amsterdam, Netherlands)
Published: September 27, 2025
Recurrence of Solitary Fibrous Tumour of the Pleura: A 20-Years Bi-centric Study with Risk Score Comparison.
Journal: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
Published: May 29, 2025
The rechallenge benefit score: A clinical decision tool for patients progressing after immunotherapy.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 28, 2025
New perspectives in the management of small cell bronchial cancer
Journal: Bulletin du cancer
Published: March 28, 2025
Real-World Outcomes of Pralsetinib in RET Fusion-Positive NSCLC.
Journal: JTO clinical and research reports
Published: July 05, 2024
Last Updated: 09/26/2026